NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes

NCT01707979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2012-10-16

No results posted yet for this study

Summary

The aim of the study is to examine the suitability to detect diabetic neuropathy using NIR and impedance.

Conditions

  • Diabetic Neuropathy

Sponsors & Collaborators

  • Lise Tarnow

    lead OTHER

Principal Investigators

  • Lise Tarnow, Professor · Steno Diabetes Center Copenhagen

Eligibility

Min Age
35 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01707979 on ClinicalTrials.gov